Location History:
- Goteborg, SE (1996)
- Göteborg, SE (2002 - 2015)
- Gothenburg, SE (2015 - 2018)
Company Filing History:
5 out of 8 
1 out of 3 
1 out of 184 Years Active: 1996-2018
Title: Eva Jennische: Innovator in Pharmaceutical Delivery Systems
Introduction
Eva Jennische is a prominent inventor based in Göteborg, Sweden. She has made significant contributions to the field of pharmaceutical sciences, particularly in optimizing cellular uptake of therapeutic agents. With a total of eight patents to her name, her work has the potential to impact various medical treatments.
Latest Patents
One of her latest patents focuses on the use of antisecretory factors (AF) for optimizing cellular uptake. This invention relates to the application of an AF protein, peptide, derivative, homologue, and/or fragment that possesses equivalent functional activity. The patent emphasizes the importance of these factors in enhancing the delivery and cellular uptake of pharmaceutical substances or formulations. These substances may include anticancer drugs, radiation therapy, antibiotics, antiviral agents, and drugs targeting posttraumatic injuries, neurodegeneration, parasites, or inflammatory conditions.
Career Highlights
Throughout her career, Eva has worked with notable companies such as Lantmännen As-faktor AB and Rural Patent Svenska AB. Her experience in these organizations has allowed her to develop and refine her innovative ideas in pharmaceutical delivery systems.
Collaborations
Eva has collaborated with esteemed colleagues, including Stefan Lange and Hans-Arne Hansson. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Eva Jennische is a trailblazer in the field of pharmaceutical innovations, with her patents paving the way for improved medical treatments. Her work exemplifies the intersection of science and innovation, making a lasting impact on healthcare.